MIR6512

Across TCGA pan-cancer cohorts, MIR6512 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated MIR6512 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR6512 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6512 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUAD show a favorable association.

ACC, MESO, and LGG are the cancer types where MIR6512 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Quartile	II,III,IV	0.527	0.887	.001	58	view →
MESO	DFS	Quartile	IV	0.107	0.403	.003	39	view →
LGG	DFS	Tertile	All	0.766	0.888	<.001	32	view →
LIHC	DFS	Quartile	All	0.184	0.325	.001	30	view →
UVM	DFS	Tertile	III,IV	0.386	0.771	.004	28	view →
SKCM	DFS	Tertile	IV	0.954	0.182	.014	19	view →
KIRP	DFS	Tertile	All	0.566	0.834	<.001	18	view →
COAD	DFS	Tertile	All	0.691	0.809	.014	18	view →
LUAD	OS	Median	All	0.853	0.767	.002	14	view →
PAAD	DFS	Tertile	All	0.198	0.410	.004	12	view →
UCS	OS	Quartile	All	0.501	0.736	.026	10	view →
DLBC	DFS	Tertile	All	0.567	0.830	.043	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

MIR6512–ACC (OS)

Open the ACC breakdown →